Clinical Trials Browser

Phase 1/2 × Nasopharyngeal Carcinoma × Gastrointestinal × Clear all

NCT02915432 2021-12-13

The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

Phase 1/2 Unknown

401 enrolled 1 FDA

GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Esophageal Squamous Cell Carcinoma

NCT03044743 2017-05-02

PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies

Phase 1/2 Unknown

GastrointestinalHead & NeckLymphoid

Nasopharyngeal Carcinoma, Hodgkin Disease, Stomach Neoplasms, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03047525 2017-02-09

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Phase 1/2 Unknown

GastrointestinalGenitourinaryHead & NeckThoracic

Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Lung Neoplasms, Colorectal Neoplasms